Journals / Kafkas Üniversitesi Veteriner Fakültesi Dergisi / 2018 / Cilt: 24 - Sayı: 2

Köpeklerde Geriatrik Kardiyoloji - Bölüm 2: Geriatrik Köpeklerde Kalp Yetmezliği Tedavisinde Zorluklar: İlaç Reaksiyonları ve Komorbitler

Geriatric Cardiology in Dogs - Part 2: Challenge with HF Therapy in Geriatric Dogs: Adverse Drug Reactions and Comorbidities

Pages
319–326
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Comorbidities (cardiorenal syndrome, hypertension, diabetes mellitus, atherosclerotic disease, metabolic syndrome, obesity, chronic obstructive pulmonary disease and frailty and cognitive dysfunction) are common, aggravate HF, complicate therapy and increase the total heart failure burden

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In geriatric dogs, aging-specific changes in cardiovascular physiology, drug metabolism, drug pharmacokinetics and drug tolerance contribute to adverse drug reactions (ADRs).
📊
Key Findings & Data:Geriatric cardiology epitomizes the principle that cardiovascular disease is only 1 component of a larger, multidimensional disease state with concomitant geriatric syndromes.
💡
Conclusion & Impact:Comorbidities (cardiorenal syndrome, hypertension, diabetes mellitus, atherosclerotic disease, metabolic syndrome, obesity, chronic obstructive pulmonary disease and frailty and cognitive dysfunction) are common, aggravate HF, complicate therapy and increase the total heart failure burden
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In geriatric dogs, aging-specific changes in cardiovascular physiology, drug metabolism, drug pharmacokinetics and drug tolerance contribute to adverse drug reactions (ADRs). Comorbidities can also cause polypharmacy and thus drug-drug interactions. Adverse drug reactions for ACE inhibitors, β–blockers, furosemide, aldosterone antagonists and digoxin are common. Geriatric cardiology epitomizes the principle that cardiovascular disease is only 1 component of a larger, multidimensional disease state with concomitant geriatric syndromes. Comorbidities (cardiorenal syndrome, hypertension, diabetes mellitus, atherosclerotic disease, metabolic syndrome, obesity, chronic obstructive pulmonary disease and frailty and cognitive dysfunction) are common, aggravate HF, complicate therapy and increase the total heart failure burden

Özet

Geriatrik köpeklerde yaşa bağlı kardiyovasküler fizyoloji, ilaç metabolizması, ilaç farmakokinetiği ve ilaç töleransındaki değişiklikler ilaç yan etki reaksiyonlarına yol açar. Komorbitler de polifarmasiye ve böylece ilaç-ilaç etkileşimlerine neden olabilir. ACE inhibitörleri, ?-blokörler, furosemid, aldosteron antagonistleri ve digoxin'e karşı ilaç reaksiyonları yaygındır. Geriatrik kardiyoloji, kardiyovasküler hastalığın geriatrik sendromlarla birlikte çok boyutlu bir oluşumun bir komponentini temsil eder. Komorbidler (kardiyorenal sendrom, hipertansiyon, diabetes mellitus, atherosklerotik hastalık, metabolik sendrom, obesite, kronik obstrüktif pulmoner hastalık ve güçsüzlük ve kognitif disfonksiyon) yaygındır, kalp yetmezliğini şiddetlendirirler ve tedaviyi komplike hale getirirler

🔖

Cite This Article

İNCE, M. E., ERTAN, M., SÜLEYMANOĞLU, H., TURGUT, K. (2018). Köpeklerde Geriatrik Kardiyoloji - Bölüm 2: Geriatrik Köpeklerde Kalp Yetmezliği Tedavisinde Zorluklar: İlaç Reaksiyonları ve Komorbitler. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 24 - Sayı: 2, 319–326. https://ajindex.com/articles/272207

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Bell SP, Orr NM, Dodson JA, Rich MW, Wenger NK, Blum K, Harold JG, Tinetti ME, Maurer MS, Forman DE: What to expect from the evolving field of geriatric cardiology? J Am Coll Cardiol, 66 (11): 1286-1299, 2015. DOI: 10.1016/j.jacc.2015.07.048 2. Turgut K: Klinik Kedi ve Köpek Kardiyolojisi. Nobel Tıp Kitabevleri Tic. Ltd. Şti., İstanbul, 2017. 3. Hamlin RL: Geriatric heart diseases in dogs. Vet Clin North Am: Small Anim Pract, 35, 597-615, 2005. DOI: 10.1016/j.cvsm.2005.01.003 4. Goldwater DS: Geriatric cardiology: A fellow’s perspective. J Am Coll Cardiol, 64 (13): 1401-1403, 2014. DOI: 10.1016/j.jacc.2014.08.009 5. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-preserved trial. Lancet, 362, 777-781, 2003. DOI: 10.1016/S0140-6736(03)14285-7 6. Cicardi M, Zingale LC, Bergamaschini L, Agostoni A: Angioedema associated with angiotensin-converting enzyme inhibitor use: Outcome after switching to a different treatment. Arch Intern Med, 164, 910-913, 2004. DOI: 10.1001/archinte.164.8.910 7. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW: 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 119, 14, 1977- 2016, 2009. DOI: 10.1161/CIRCULATIONAHA.109.192064 8. Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L: Acute heart failure syndromes: Current state and framework for future research. Circulation, 112, 3958-3968, 2005. DOI: 10.1161/ CIRCULATIONAHA.105.590091 9. Levy D1, Larson MG, Vasan RS, Kannel WB, Ho KK: The progression from hypertension to congestive heart failure. JAMA, 275, 1557-1562, 1996. DOI: 10.1001/jama.1996.03530440037034 10. Wilhelmsen L1, Rosengren A, Eriksson H, Lappas G: Heart failure in the general population of men: Morbidity, risk factors and prognosis. J Intern Med, 249, 253-261, 2001. DOI: 10.1111/j.1365-2796.2001.00801.x 11. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D’Agostino RB, Kannel WB, Murabito JM, Vasan RS, Ben